Study of NT-88 for heart failure with mid-range ejection fraction
Part of Heart & circulation clinical trials.
This trial tests a new medicine, NT-88, for people with a type of heart failure where the heart's pumping ability is moderately reduced (LVEF 41-49%). It aims to see if the treatment is safe and helps improve symptoms like shortness of breath and fatigue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with heart failure and have symptoms like shortness of breath, tiredness, or swelling.
- Your heart's pumping ability (LVEF) is between 41% and 49%, confirmed by an imaging test like an echocardiogram.
- Your heart failure symptoms are stable and you haven't needed a change in treatment for at least 3 months.
- You have normal thinking and memory (normal cognitive function).
- You are not pregnant, breastfeeding, or planning pregnancy, and you agree to use effective birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medicine called NNC0537-1482 for people with heart failure. It aims to see if the medicine helps improve symptoms and heart function.
This study looks for markers in the blood that can predict whether the heart's pumping function improves in people with chronic heart failure. It may help doctors understand which treatments work best for each person.
This study is testing better ways to understand and manage heart failure where the heart pumps normally but still doesn't work as well as it should. It looks at people with symptoms like shortness of breath and fatigue, using blood tests and heart imaging to check eligibility.
This study tests whether a new drug called AC01 can help people with advanced heart failure (where the heart doesn't pump well) feel better and stay healthier. You'll be randomly assigned to receive either AC01 or placebo, and researchers will monitor your heart health closely throughout the study.
This study tests whether a new medication called NNC0487-0111 can help people with heart failure who also have obesity. Researchers will compare it to a placebo (inactive pill) to see if it improves heart function and overall health.
This trial tests a new drug called HRS-1893 for people with heart failure with preserved ejection fraction (HFpEF). It aims to see if the drug can improve symptoms and quality of life.
Hear when a new Heart Failure With Mildly Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.